anxiety.
The clinical course of depression after cessation of antidepressants has not been investigated in primary care, but evidence from randomised controlled trials examining the outpatient treatment of major depression indicates that continued treatment with tricyclic antidepressants for several months after the episode has resolved may significantly reduce relapse and recurrence.37 38 Drop out rates of 22-32% have been reported in the primary care trials. Assessing the degree of compliance with treatment is problematic and a proportion of those allocated to receive antidepressants in the trials probably did not follow the prescribed regimen.39 Side effects are often reported as a reason for patients dropping out of trials, though reports of side effects are common among those taking placebo. Other factors, including perceived lack of efficacy of treatment, unhappiness about taking tablets, and improvement or deterioration of symptoms, are also common self reported reasons for dropping out.
A recent study found that around half of patients who receive treatment with antidepressants in primary care did not have major depression and so were unlikely to benefit from the treatment,40 though there is some evidence that tricyclic antidepressants may have a similar effect to benzodiazepines in the management of symptoms of anxiety and sleep disorders.4' Patients with major depression may also be prescribed antidepressants at doses lower than those shown to be effective,42 and many patients who are recognised as having major depression may stop taking their treatment in the first few weeks42 43 Family health services authorities and district health authorities should consider allocating resources to fund suitably qualified therapists to undertake congnitive therapy for those depressed patients who may not otherwise receive adequate treatment for major depression. Despite the absence of clear evidence for the effectiveness of counselling family health services authorities may also consider funding counsellors or providing and training other professionals to help GPs to care for the large numbers of patients with depression and psychological problems other than those with major depression.
Clinical guidelines for managing depression will be influenced by the available services locally, but they should include the following: * Criteria for detecting or recognising major depression in primary care, based on DSM-III-R, ICD (tenth revision), or other similar and acceptable diagnostic classifications * Clear advice about appropriate treatment packages, including explicit criteria for prescribing different drug treatments. The guidelines may include a limited list of drugs, ensuring that expensive preparations are reserved for patients with specific drug needs, such as low cardiotoxicity or safety in overdose, or those who have failed to benefit from more conventional treatments * Consideration of strategies for improving compliance with treatments -which may entail longer initial appointments to allow treatment options to be discussed and agreed between patients and GPs and possible side effects to be discussed * Explicit criteria for referral to secondary care services, which should include an option for advice under which the GP might gain help in assessing and planning a patient's management, without necessarily transferring care to the secondary sector. Other possible forms of collaboration between the secondary and primary care sectors may flourish where the organisation of services favours partnership between professional and voluntary groups * Specification of audit measures to ensure the quality of services. Audit measures should include rate of identification of major depression against a screened population of GP attendees, referrals by GPs to other professionals, prescription of different drugs, identifying the numbers of patients with major depression who miss follow up appointments and ascertaining the reasons for defaulting in a proportion of them.
